SCHEMBL7409657

SCHEMBL7409657

CN(C(=O)C(CC1CCCCC1)NC(=O)c1ccncc1)C1(C#N)CCNCC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSS P25774 9/20 0.60
CTSL P07711 8/20 0.60
CTSB P07858 5/20 0.49
CTSK P43235 3/20 0.46
GPR132 Q9UNW8 1/20 0.37
GRN P28799 1/20 0.37
SORT1 Q99523 1/20 0.37
HTRA1 Q92743 1/20 0.36
CPB2 Q96IY4 1/20 0.35
PREP P48147 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
USP30 Q70CQ3 1/20 0.35
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417185 0.91 CTSL (0.57) CTSSCTSLCTSBCTSKGRN
SCHEMBL7410718 0.89 CTSS (0.47) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414894 0.87 CTSS (0.45) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414674 0.85 CTSS (0.45) CTSSCTSLCTSBCTSKUSP30
SCHEMBL7026883 0.82 CTSS (0.52) CTSSCTSLCTSBCTSKGPR132
SCHEMBL7414009 0.82 USP30 (0.46) CTSSCTSLCTSBCTSKCHRNB2
SCHEMBL5528488 0.81 CTSL (0.62) CTSSCTSLCTSBCTSKGPR132
SCHEMBL7415423 0.77 CTSS (0.43) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414874 0.74 CTSS (0.46) CTSSCTSLCTSBCTSKCHRNB2
SCHEMBL5528491 0.74 CTSL (0.81) CTSSCTSLCTSBCTSKCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed